These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3114679)

  • 61. Hepatic veno-occlusive disease associated with comfrey ingestion.
    Yeong ML; Swinburn B; Kennedy M; Nicholson G
    J Gastroenterol Hepatol; 1990; 5(2):211-4. PubMed ID: 2103401
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prospective study and long-term follow-up of liver damage in renal transplant recipients.
    Takahara S; Ihara H; Ichikawa Y; Nagano S; Fukunishi T; Sonoda T; Shinji Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2221-4. PubMed ID: 3547920
    [No Abstract]   [Full Text] [Related]  

  • 63. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.
    Arnott ID; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):569-73. PubMed ID: 10833103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient.
    Shah S; Budev M; Blazey H; Fairbanks K; Mehta A
    Eur Respir J; 2006 May; 27(5):1066-8. PubMed ID: 16707401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatic dysfunction in recipients of renal allografts.
    Berne TV; Chatterjee SN; Craig JR; Payne JE
    Surg Gynecol Obstet; 1975 Aug; 141(2):171-5. PubMed ID: 168654
    [No Abstract]   [Full Text] [Related]  

  • 67. Hepatic veno-occlusive lesions in severe alcoholic hepatitis and alcoholic liver cirrhosis: a comparative histopathological study in autopsy cases.
    Kishi M; Maeyama S; Ogata S; Koike J; Uchikoshi T
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):47S-51S. PubMed ID: 10235278
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peliosis hepatis after long-term androgen therapy.
    Nuzzo JL; Manz HJ; Maxted WC
    Urology; 1985 May; 25(5):518-9. PubMed ID: 3992778
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Veno-occlusive disease and peliosis of the liver after thorotrast administration.
    Dejgaard A; Krogsgaard K; Jacobsen M
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):87-94. PubMed ID: 6426155
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites.
    Russell RM; Boyer JL; Bagheri SA; Hruban Z
    N Engl J Med; 1974 Aug; 291(9):435-40. PubMed ID: 4843409
    [No Abstract]   [Full Text] [Related]  

  • 71. [Peliosis hepatis of late onset in a patient exposed to vinyl chloride and treated for hepatic angiosarcoma].
    Paliard P; Valette PJ; Berger F; Contassot JC; Partensky C
    Gastroenterol Clin Biol; 1991; 15(5):445-8. PubMed ID: 2070967
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication.
    Huet PM; Guillaume E; Cote J; Légaré A; Lavoie P; Viallet A
    Gastroenterology; 1975 May; 68(5 Pt 1):1270-7. PubMed ID: 1126603
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Veno-occlusive disease of the liver induced by low-dose cyclophosphamide.
    Modzelewski JR; Daeschner C; Joshi VV; Mullick FG; Ishak KG
    Mod Pathol; 1994 Dec; 7(9):967-72. PubMed ID: 7892168
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peliosis hepatis in the acquired immunodeficiency syndrome.
    Czapar CA; Weldon-Linne CM; Moore DM; Rhone DP
    Arch Pathol Lab Med; 1986 Jul; 110(7):611-3. PubMed ID: 3755024
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Peliosis hepatis, oral contraceptives and hepatic carcinoma: a case treated surgically (author's transl)].
    Tocornal J; Rosenberg H
    Rev Med Chil; 1981 Mar; 109(3):236-8. PubMed ID: 6269168
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The liver side effects of azathioprine].
    Böker KH
    Dtsch Med Wochenschr; 1999 Apr; 124(17):541. PubMed ID: 10341765
    [No Abstract]   [Full Text] [Related]  

  • 77. [Reversible azathioprine associated dysmyeloproliferative syndrome after kidney allotransplantation].
    Bammatter F; Binswanger U; Fehr J
    Klin Wochenschr; 1987 Jul; 65(13):620-4. PubMed ID: 3306135
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients.
    Lee H; Ainechi S; Singh M; Ells PF; Sheehan CE; Lin J
    Int J Surg Pathol; 2015 Sep; 23(6):439-46. PubMed ID: 25882443
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
    Tuyama AC; Krakauer M; Alzaabi M; Fiel MI; Legnani P; Schiano TD
    J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Peliosis hepatis in a kidney transplant recipient with manifestation as massive ascites and liver dysfunction: case report.
    Lui WH; Chou TC; Chang SS; Hung CJ; Lin YJ; Lee PC
    Transplant Proc; 2014; 46(2):630-3. PubMed ID: 24656031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.